The Liquid Argon Jet Trigger of the H1 Experiment at HERA

We report on a novel trigger for the liquid argon calorimeter which was installed in the H1 Experiment at HERA.This trigger, called the “Jet Trigger”, was running at level 1 and implemented a real-time cluster algorithm. Within only 800 ns, the Jet Trigger algorithm found local energy maxima in the calorimeter, summed their immediate neighbors, sorted the resulting jets by energy, and applied topological conditions for the final level 1 trigger decision. The Jet Trigger was in operation from the year 2006 until the end of the HERA running in the summer of 2007. With the Jet Trigger it was possible to substantially reduce the thresholds for triggering on electronsand jets, giving access to a largely extended phase space for physical observables which could not have been reached in H1 before. The concepts of the Jet Trigger may be an interesting upgrade option for the LHC experiments

Effect of Platelet-activating Factor on in vitro and in vivo Interleukin-6 Production

The aim of the present study was to investigate the possible effect of platelet-activating factor (PAF), by comparison with interleukin-1β and polyriboinositic/polyribocytidylic (poly I–C) acid, on IL-6 production by L 929 mouse fibroblasts. At concentrations above 1 μM PAF, the production of IL-6 by mouse fibroblasts was enhanced in a dose dependent fashion. At 5 μM PAF, the peak increase (60.1 ± 19.4 U/ml) was similar to that induced by 50 μg/ml poly I–C (60.0 ± 35.0 U/ml) and higher than the one evoked by 100 U/ml IL-1β (3.8 ± 1.8 U/ml). The increase of 11-6 activity induced by 5 μM PAF was maximal after a 22 h incubation period with L 929 cells. Lyso-PAF (5 μM) also increased IL-6 activity from fibroblasts to a similar extent compared with 5 μM PAF. In addition, the IL-6 activity induced by 5 μM PAF was still observed when the specific PAF antagonist, BN 52021 (10 μM), was added to the incubation medium of L 929 cells. The result suggests that the production of IL-6 by L 929 cells evoked by PAF in vitro is not receptor mediated. The in vivo effect of PAF on IL-6 production was also investigated in the rat. Two hours after intravenous injection of PAF (2 to 4 μg/kg), a dramatic increase of IL-6 activity in rat serum was observed, this effect being dose dependent. The increase of IL-6 induced by 3 μg/kg PAF was not observed when the animals were treated with the PAF antagonist, BN 52021 (1 to 60 mg/kg0. These results demonstrate that PAF modulates IL-6 production and that the in vivo effect is receptor mediated

Effect of Platelet-Activating Factor on Monocyte Activation and Production of Tumor Necrosis Factor

The effect of platelet-activating factor (PAF) or human peripheral-blood-derived monocytes (PBM) was examined. The addition of PAF to monocyte cultures did not activate the cells to mediate cytotoxicity activity against &lt;sup&gt;51&lt;/sup&gt;Cr-labeled target cells. Furthermore, supernatants derived from the treated cultures were not cytotoxic. However, these supernatants contained tumor necrosis factor (TNF) when assayed by a sensitive radioimmunoassay. Further kinetic studies indicated that cytotoxic supernatant is detected at 2–4 h following PAF treatment but not overnight treatment, suggesting, perhaps, the presence of inhibitors interfering with the cytotoxic activity. Cells pretreated with PAF responded poorly to a second stimulation with phorbol myristate acetate whereas a secondary response was seen with cells pretreated with interferon-γ. These results suggest that PAF is involved in regulating cytokine production by monocytes and thus plays a role in the immune response to foreign antigens.</jats:p